Ranolazine and the Myocardial Demand–Supply Balance
Author(s) -
Francis J. Klocke
Publication year - 2009
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2009.09.008
Subject(s) - ranolazine , balance (ability) , supply and demand , business , cardiology , medicine , economics , macroeconomics , physical medicine and rehabilitation
The emergence of ranolazine as an effective antianginal agent ([1,2][1]) has prompted recurring interest in identifying mechanisms by which this agent can favorably affect the imbalance between myocardial oxygen demand and supply underlying anginal episodes.Early studies of ranolazine centered on
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom